PMID: 12716733Apr 30, 2003

Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes

Diabetes
Carla J GreenbaumImmunology of Diabetes Society

Abstract

No abstract listed.

References

C-peptide secretion during the remission phase of juvenile diabetes

Jun 1, 1978·Diabetes·E HeinzeE F Pfeiffer

Standardization of IVGTT to predict IDDM

Oct 1, 1992·Diabetes Care·Polly J BingleyEdwin A M Gale

Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop

Dec 1, 1992·Diabetes·Carla J GreenbaumA Lernmark

Comparison of two commonly used standard IVGTTs

Aug 1, 1992·Diabetes Care·P G ColmanLeonard C Harrison

Factors predicting course of beta-cell function in IDDM

Aug 1, 1992·Diabetes Care·A SchiffrinD Lalla

Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories

Aug 1, 1992·Diabetologia·Carla J GreenbaumJ P Palmer

Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group

Apr 1, 1992·Journal of Diabetes and Its Complications·Jay S Skyler, A Rabinovitch

The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories

Jul 1, 1991·Diabetologia·A LernmarkN Maclaren

Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes

Jan 1, 1991·Diabetes Research and Clinical Practice·J J CouperLeonard C Harrison

Glucose tolerance behaviour before the onset of type I (insulin-dependent) diabetes in young people as a predictor of the further course of the disease: a retrospective analysis of 33 cases

Feb 1, 1991·Diabetes Research and Clinical Practice·I RjasanowskiW Hildmann

Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays

Dec 1, 1990·Diabetologia·Ezio BonifacioG F Bottazzo

A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus

Jul 1, 1990·Diabetologia·H P ChaseD O'Brien

Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group

Feb 1, 1990·Diabetes·Thomas Mandrup-PoulsenM Munck

Prednisone administration in recent onset type I diabetes

Oct 1, 1990·Journal of Autoimmunity·A SecchiG Pozza

Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus

Oct 1, 1990·Journal of Autoimmunity·C GiordanoA Galluzzo

Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients

Mar 1, 1989·Diabetologia·G MendolaR Gomis

Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients

May 1, 1989·Diabetologia·P VagueB Vialettes

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

Mar 2, 1989·The New England Journal of Medicine·S C ShahN E Simpson

Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes

Jun 1, 1989·Diabetes·J J CookJ M Court

Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study

Nov 1, 1989·Diabetes·M PeigR Pujol-Borrell

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

Jul 1, 1987·The Journal of Clinical Endocrinology and Metabolism

Reproducibility of the glucagon test

Jul 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·S Arnold-LarsenC Kühl

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus

Sep 8, 1988·The New England Journal of Medicine·J SilversteinS Johnson

Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Held in New York, New York, October 1987

Jul 1, 1988·Diabetologia·C BoitardJ Molenaar

Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children

Sep 1, 1988·Diabetologia·Johnny LudvigssonThomas Mandrup-Poulsen

Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies

Jan 21, 1988·Journal of Immunological Methods·Ezio BonifacioR L Dawkins

The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987

Jul 1, 1988·Diabetologia·T WilkinJ L Diaz

Prospective study of predictors of beta-cell survival in type I diabetes

Jul 1, 1988·Diabetes·A SchiffrinG Weitzner

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children

Jul 1, 1987·Diabetologia·E B SochettR M Ehrlich

C-peptide: an index of insulin secretion

Jan 1, 1986·Diabetes/metabolism Reviews·O K Faber, C Binder

Outcome of the glucagon test depends upon the prevailing blood glucose concentration in type I (insulin-dependent) diabetic patients

Jan 1, 1987·Acta Medica Scandinavica·S MadsbadC Kühl

Practical aspects in performing the glucagon test in the measurement of C-peptide secretion in diabetic patients

Jun 1, 1986·Scandinavian Journal of Clinical and Laboratory Investigation·T Rönnemaa

Meal-stimulated C-peptide and insulin antibodies in type I diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens

May 1, 1985·Diabetes·B J HoogwerfJ J Barbosa

Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine

Dec 1, 1985·Diabetes·Leonard C HarrisonF I Martin

Carbimazole and the autoimmune response in Graves' disease

Aug 7, 1980·The New England Journal of Medicine·A M McGregorR Hall

Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control

Jan 1, 1983·Acta Medica Scandinavica·S SjöbergJ Ostman

Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features

Oct 1, 1984·Acta diabetologica latina·E BonoraU Butturini

C-peptide response to arginine stimulation in diabetic children

Mar 1, 1980·The Journal of Pediatrics·M MenchiniG Chiumello

C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide

Sep 1, 1980·Diabetologia·R D MirelE J Rayfield

Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)

Jul 1, 1995·Diabetologia·Paolo PozzilliD Andreani

Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose

Aug 1, 1995·Diabetes Care·P D McNairLeonard C Harrison

Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team

Oct 1, 1993·Journal of Diabetes and Its Complications·Jay S SkylerV Byers

HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus

Feb 1, 1995·Human Immunology·B D TaitM C Honeyman

Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes

Dec 1, 1993·Diabetes/metabolism Reviews·A MuirN Maclaren

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency

Apr 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·P Z ZimmetD A Lang

High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop

Aug 1, 1994·Diabetes·R S SchmidliLeonard C Harrison

Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group

Jan 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·Paolo PozzilliL Lucentini

Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. The ICARUS Group. Islet Cell Antibody Register User's Study

Jun 1, 1993·Diabetes Care·D K McCullochEdwin A M Gale

Effects of a short prednisone regime at clinical onset of type 1 diabetes

Apr 1, 1993·Diabetes Research and Clinical Practice·A GodayR Gomis

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

Sep 30, 1993·The New England Journal of Medicine·Diabetes Control and Complications Trial Research GroupC Siebert

Determinants of clinical remission in recent-onset IDDM

Jan 1, 1993·Diabetes Care·I M HramiakD T Finegood

Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM

May 1, 1996·Diabetes·T KobayashiK Kosaka

Cellular immune response to diverse islet cell antigens in IDDM

Jun 1, 1996·Diabetes·I Durinovic-BellòA G Ziegler

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies

Jul 1, 1996·Diabetes·C F VergeGeorge S Eisenbarth

Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice

Aug 1, 1996·Diabetes·A ShimadaC G Fathman

Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM

Jan 1, 1996·Diabetes Care·I YokotaY Kuroda

Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes

Jan 1, 1996·International Journal of Clinical & Laboratory Research·K D KohnertD Michaelis

Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes

Oct 1, 1996·Diabetes·E BjörkF A Karlsson

Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy

Nov 1, 1996·Clinical and Experimental Immunology·G KahalyG Hommel

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study

Dec 1, 1996·Diabetes·Polly J Bingley

Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients

Dec 1, 1996·Metabolism: Clinical and Experimental·T LinnK Federlin

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM

Oct 6, 1997·Diabetes·O SchnellA G Ziegler

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

Jun 10, 1998·Annals of Internal Medicine

IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes

Aug 26, 1998·Human Immunology·J J CouperA Ferrante

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial

Oct 1, 1998·Diabetologia·R CoutantP Bougnères

Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM

Oct 17, 1998·Diabetes Care·J F ElliottR M Couch

Neural network-based prediction of candidate T-cell epitopes

Oct 27, 1998·Nature Biotechnology·M C HoneymanLeonard C Harrison

Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus

Oct 31, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·R BonfantiEzio Bonifacio

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

Dec 4, 1998·Diabetes·C F VergeGeorge S Eisenbarth

The NOD mouse model of type 1 diabetes: as good as it gets?

Jun 17, 1999·Nature Medicine·Mark A Atkinson, E H Leiter

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

Sep 10, 1999·Journal of Autoimmunity·Bart O RoepJ A Sachs

Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study

Oct 20, 1999·Diabetes Care·H F AllenH P Chase

A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group

Feb 3, 2000·The New England Journal of Medicine·A ImagawaY Matsuzawa

Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes

Jun 27, 2000·Diabetes Care·J VidalI Conget

A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus

Jul 20, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·B A Buckingham, C I Sandborg

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group

Aug 19, 2000·Lancet·L ChaillousP Saï

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group

Sep 16, 2000·Diabetologia·Paolo PozzilliG Ghirlanda

A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence

Dec 29, 2000·Annals of Medicine·A ImagawaY Matsuzawa

Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage

Mar 27, 2001·Autoimmunity·C TörnG Sundkvist

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria

Mar 29, 2001·Diabetes·Carla J GreenbaumDisease Prevention Trial of Type I Diabetes Study Group

Citations

Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial

Jul 5, 2005·Diabetologia·I CongetF Nicoletti

Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study

Sep 20, 2012·Diabetologia·D DabeleaR D'Agostino

Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials

Mar 24, 2004·Current Diabetes Reports·George S Eisenbarth

Progress, but not yet ready for clinical use: interrupting immune-mediated destruction of pancreatic beta cells in type 1 diabetes

Mar 18, 2006·Current Diabetes Reports·Carla J Greenbaum

Microdialysis-coupled enzymatic microreactor for in vivo glucose monitoring in rats

Nov 10, 2013·Analytical Chemistry·Byeong-Ui MoonElisabeth Verpoorte

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud

Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes

Jun 28, 2013·Science Translational Medicine·Bart O RoepLawrence Steinman

Lowering physical activity impairs glycemic control in healthy volunteers

Jul 1, 2011·Medicine and Science in Sports and Exercise·Catherine R MikusJohn P Thyfault

Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset

May 12, 2007·The Review of Diabetic Studies : RDS·Frantisek SaudekJelena Skibova

Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes

Nov 1, 2012·Diabetes Care·R E J BesserJohnny Ludvigsson

Response to comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201

Nov 23, 2013·Diabetes Care·B M ShieldsJohnny Ludvigsson

Combination therapy for preservation of beta cell function in Type 1 diabetes: new attitudes and strategies are needed!

Mar 1, 2014·Immunology Letters·Johnny Ludvigsson

A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy

Nov 23, 2005·Pediatric Clinics of North America·Anna CasuMassimo Pietropaolo

Challenges in developing endpoints for type 1 diabetes intervention studies

Sep 23, 2009·Diabetes/metabolism Research and Reviews·Simona CerneaD-Cure Workshop

Current literature in diabetes

Sep 3, 2003·Diabetes/metabolism Research and Reviews

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Oct 1, 2008·Pediatric Diabetes·Jeffrey L MahonType 1 Diabetes TrialNet Study Group

Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease

Feb 17, 2007·Clinical and Experimental Immunology·C BakerC M Dayan

Simple measures to monitor beta-cell mass and assess islet graft dysfunction

Dec 19, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Raquel N FaradjiRodolfo Alejandro

Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials

Jan 16, 2008·Clinical Endocrinology·Gunjan Y GandhiYogish C Kudva

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients

Dec 14, 2011·Pediatric Diabetes·Suzanne E KingeryC Yung Yu

The impact of insulin administration during the mixed meal tolerance test

Mar 23, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·R E J BesserA T Hattersley

Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes

Apr 27, 2011·Pediatric Diabetes·Kathryn M SumpterPerrin C White

Parenteral insulin suppresses T cell proliferation to islet antigens

Jun 5, 2010·Pediatric Diabetes·Carla J GreenbaumBarbara Brooks-Worrell

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

Jul 16, 2010·Clinical and Experimental Immunology·J B MatthewsITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study

Jun 7, 2005·Diabetes Research and Clinical Practice·Paolo PozzilliIMDIAB group

Disease prevention with islet autoantigens

Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·George S Eisenbarth, Jean M Jasinski

Treatment of type 1 diabetes mellitus to preserve insulin secretion

Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Kevan C Herold

Strategies for clinical trials in type 1 diabetes

Apr 14, 2016·Journal of Autoimmunity·Mario R Ehlers

Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus

Jun 16, 2015·Pediatric Diabetes·Marianna RachmielYael Lebenthal

Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal

Jan 11, 2014·Diabetes Care·Paolo PozzilliIrun R Cohen

Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9

Jan 13, 2015·BMC Endocrine Disorders·Marta HernandezAction LADA consortium

Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control

Dec 24, 2009·Diabetes Care·Maria Anita RadtkeValdemar Grill

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

Jul 17, 2008·Diabetes Care·Carla J GreenbaumEuropean C-Peptide Trial Study Group

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

Oct 2, 2009·Diabetes Care·Marian Rewers, Peter Gottlieb

Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination

Nov 25, 2003·Diabetes Care·Desmond SchatzMark A Atkinson

GABAergic system in β-cells: from autoimmunity target to regeneration tool

Oct 26, 2013·Diabetes·Paolo Fiorina

Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual β-cell function in children with type 1 diabetes

Sep 13, 2016·Pediatric Diabetes·Małgorzata PawłowiczJanusz Limon

Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes

Apr 4, 2017·Diabetes/metabolism Research and Reviews·C GuglielmiPaolo Pozzilli

A Practical Review of C-Peptide Testing in Diabetes

May 10, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Emma LeightonGregory C Jones

The role of immunomodulation therapy in autoimmune diabetes

Feb 11, 2010·Journal of Diabetes Science and Technology·Johnny Ludvigsson, Linköping Diabetes Immune Intervention Study Group

Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction

Dec 17, 2009·Cell Transplantation·Raquel N FaradjiRodolfo Alejandro

Long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetes

Sep 22, 2018·Immunotherapy·Avivit BrenerMarianna Rachmiel

Capturing residual beta cell function in type 1 diabetes

Nov 6, 2018·Diabetologia·Flemming Pociot

Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy

Oct 6, 2007·Diabetes/metabolism Research and Reviews·M ChianelliIMDIAB study group

Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes

Dec 17, 2019·Pediatric Diabetes·Jens Otto Broby MadsenJesper Johannesen

Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry

Apr 15, 2006·Clinical Chemistry·Diego Rodríguez CabaleiroLinda M Thienpont

Decreased markers of bone turnover in children and adolescents with type 1 diabetes

Jan 24, 2020·Pediatric Diabetes·Jens Otto Broby MadsenJesper Johannesen

Association of vaginal delivery efforts with retinal disease in women with type I diabetes

Oct 1, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Maisa FeghaliMenachem Miodovnik

Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment

Jun 12, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bas S UitbeijerseEelco J P de Koning

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001

Dec 25, 2003·Diabetes·Jerry P PalmerMichael W Steffes

Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset

Dec 16, 2018·Diabetes Care·John VirostkoDaniel J Moore

Related Concepts

Diabetes, Autoimmune
Islets of Langerhans
Microdosing Trials, Human
Evaluation Studies, FDA Phase II as Topic

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

ContactHelpTerms Privacy Cookies Blog
© 2021 Meta ULC. All rights reserved